Researchers suggest RIOK 1 as a new target for cancer therapeutics
A group led by Tilman Brummer (University of Freiburg, Breisgau, Germany) has collaborated with an international team of researchers to identify a new target for cancer therapy; RIOK1.
Please sign in or register for FREE to view this content
Sign in to MedChemNet
Register to MedChemNet – the medicinal chemistry network
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.